https://www.selleckchem.com/pr....oducts/gsk-lsd1-2hcl
without discontinuation of life-prolonging taxane therapy. To describe a novel surgical treatment option for managing a symptomatic filtration bleb extending into the three quadrants with adequate IOP control after Xen gel stent implantation. A 62-year-old female with pseudoexfoliative glaucoma with an IOP of 34 mmHg underwent implantation of a Xen to reduce the IOP in her right eye. The IOP responded well to the procedure, but the patient developed a persistent giant filtration bleb with foreign body sensation and pain. A huge fi
Me gusta
Comentario
Compartir
